Mbesuma's deal falls through
Mbesuma was set to sign with the Israeli team after impressing the club's technical team but the deal fell through after their coach was fired.
Bausch + Lomb will acquire Ista Pharmaceuticals for approximately $500 million, or $9.10 per share, according to a Bausch + Lomb news release.